Following its midstage coronavirus R&D setback, vaccine giant Sanofi is still looking for ways to help in the world’s effort to beat back the pandemic. It’s teaming up with leading vaccine players Pfizer and BioNTech to produce 100 million doses of the rival vaccine—even as Sanofi works to push its own programs through clinical testing.

The first batches will be delivered from Sanofi’s site in Frankfurt, Germany, by August. Source: Fierce Pharma 26/1/2021.